Novartis Boosts Forecast Again as New Gene Therapy Shines

Bookmark
(Bloomberg) -- Novartis AG raised its earnings forecast for the third time this year as new drugs including gene therapy Zolgensma got off to a strong start.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.